Longhini, Federico
Pasin, Laura
Montagnini, Claudia
Konrad, Petra
Bruni, Andrea
Garofalo, Eugenio
Murabito, Paolo
Pelaia, Corrado
Rondi, Valentina
Dellapiazza, Fabrizio
Cammarota, Gianmaria
Vaschetto, Rosanna
Schultz, Marcus J.
Navalesi, Paolo
Article History
Received: 1 November 2020
Accepted: 17 June 2021
First Online: 30 June 2021
Declarations
:
: The study was approved by the local Ethics Committee of the Maggiore della Carità Hospital, in Novara (Italy) on the 10th October 2014 (protocol n° 134/14). All patients provided written informed consent to participate in the trial, according to the national regulations.
: All patients gave consent for data publication according to national regulations.
: No conflict related to the present work. Dr. Navalesi’s research laboratory has received equipment and grants from Maquet Critical Care, Draeger and Intersurgical S.p.A. He also received honoraria/speaking fees from Maquet Critical Care, Orionpharma, Philips, Resmed, MSD and Novartis. Dr. Navalesi contributed to the development of the helmet Next, whose licence for patent belongs to Intersurgical S.P.A., and receives royalties for that invention. Dr. Longhini and Dr. Navalesi contributed to the development of a new device not discussed in the present study (European Patent number 3320941, released on 5th August 2020). The remaining authors have no conflict of interest to disclose.